Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04502225 · ClinicalTrials.gov registry record · NA

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure

A NA study of Autonomic Failure and Supine Hypertension, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT04502225: Recruiting NA study of Autonomic Failure and Supine Hypertension, sponsored by Vanderbilt University Medical Center.

NCT04502225 is a NA study of Autonomic Failure and Supine Hypertension that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 44 participants, above the 35-participant average among 11 other Autonomic Failure trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04502225, a NA study of Autonomic Failure and Supine Hypertension, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venous return to the heart (achieved by raising the head of the bed) to lessen supine blood pressure. If decreased venous return to the heart is effective at lowering supine blood pressure, these approaches may be utilized to treat supine hypertension non-pharmacologically. Raising the head of the bed decreases the amount of blood returning to the heart due to the effects of gravity. In this case, the decreased blood return to the heart may decrease blood pressure.

Primary Outcome

Maximal change from baseline in systolic blood pressure during the night

Interventions

  • OTHER Tilt
  • OTHER Elevated trunk
  • OTHER Tilt - In home
  • OTHER Elevated Trunk - In home

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2020-08-21
Est. Completion 2026-12-31
Phase NA

What NCT04502225 shows while recruiting

NCT04502225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, above the 35-participant average among 11 other Autonomic Failure trials with a reported enrollment target (26% higher).

The record links to 2 conditions, with Autonomic Failure appearing as the primary indexed condition, and to 4 interventions - of which Tilt is the first listed.

NCT04502225 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT04502225 about?

NCT04502225 is a clinical study titled "Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure". Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venous return to the heart (achieved by raising the head of the bed) to lessen supine blood pressure. If decreased venous return to the heart is e...

What is the current status of trial NCT04502225?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2020-08-21. Estimated completion is 2026-12-31.

What conditions does trial NCT04502225 study?

This clinical trial studies the following conditions: Autonomic Failure, Supine Hypertension.

What interventions are being tested in trial NCT04502225?

The interventions under investigation include: Tilt (OTHER), Elevated trunk (OTHER), Tilt - In home (OTHER), Elevated Trunk - In home (OTHER).

Who is sponsoring clinical trial NCT04502225?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04502225 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autonomic Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04502225's enrollment target sits among peer trials

44 3rd of 11 higher than 9 of 11 other Autonomic Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autonomic Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04502225, the US trial registry maintained by the National Library of Medicine. NCT04502225 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.